912347-94-5

Basic information

• Product Name: 2-Methyl-3-amino-4-acetylanisole
• Synonyms: Ethanone, 1-(2-amino-4-methoxy-3-methylphenyl)-;2-methyl-3-amino-4-acetylanisole;1-(2-Amino-4-methoxy-3-methylphenyl)ethanone;6-ACETYL-3-METHOXY-2-METHYL ANILINE;2-Amino-4-methoxy-3-methylbenzoic acid;1-(2-aMino-4-Methoxy-3-Methylphenyl)-;1-(2-aMino-4-Methoxy-3-Methylphenyl)ethan-1-one;2-AMino-4-Methoxy-3-Methylacetophenone
• CAS NO: 912347-94-5
• Molecular Formula: C₁₀H₁₃NO₂
• Molecular Weight: 179.22
• EINECS: 1312995-182-4
• Product Categories: Drug Intermediates;Multisubstituted Benzene;Amino Acid Derivatives
• Mol File: 912347-94-5.mol
• Article Data: 8

Chemical Properties

• Melting Point: 107 °C
• Boiling Point: 336.02 °C at 760 mmHg
• Flash Point: 171.127 °C
• Appearance: /
• Density: 1.096 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.549
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 1.74±0.10(Predicted)
• CAS DataBase Reference: 2-Methyl-3-amino-4-acetylanisole(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Methyl-3-amino-4-acetylanisole(912347-94-5)
• EPA Substance Registry System: 2-Methyl-3-amino-4-acetylanisole(912347-94-5)

Safety Data

• Hazardous Substances Data: 912347-94-5(Hazardous Substances Data)

Usage

General Description

2-Methyl-3-amino-4-acetylanisole, also known as Leucovanillone, is a chemical compound with the molecular formula C10H13NO2. It is commonly used in the fragrance and flavor industry due to its sweet, vanilla-like odor. 2-Methyl-3-amino-4-acetylanisole is frequently utilized as a flavoring agent in food products and as a fragrance in perfumes and other scented products. It is a pale yellow to brownish liquid with a strong, sweet odor and is often used to enhance the flavor and aroma of various food and beverage products. Additionally, it has been found to have antioxidant and antimicrobial properties, making it useful in a variety of applications.

InChI:InChI=1/C10H13NO2/c1-6-9(13-3)5-4-8(7(2)12)10(6)11/h4-5H,11H2,1-3H3

Upstream product

• 923274-68-4 2-amino-4-methoxy-3-methylbenzonitrile 
• 75-16-1 methylmagnesium bromide 
• 75-05-8 acetonitrile 
• 19500-02-8 2-methyl-3-methoxyaniline 

Downstream Products

• 923604-99-3 6-isopropylpyridine-2-carboxylic acid (6-acetyl-3-methoxy-2-methylphenyl)amide 
• 923289-16-1 C₁₄H₁₄N₂O₃S 
• 923604-91-5 6-methylpyridine-2-carboxylic acid (6-acetyl-3-methoxy-2-methylphenyl)-amide 
• 923289-20-7 N-(6-acetyl-2-methyl-3-methoxyphenyl)-4-isopropylthiazole-2-carboxamide 
• 923605-09-8 2-cyclohexylthiazole-4-carboxylic acid (6-acetyl-3-methoxy-2-methylphenyl)amide 
• 1237745-86-6 N-(6-acetyl-3-methoxy-2-methylphenyl)-4-cyclopropylthiazole-2-carboxamide 
• 1218999-05-3 C₁₅H₁₆N₂O₄ 
• 1180496-09-6 4-bromo-thiazole-2-carboxylic acid-(6-acetyl-3-methoxy-2-methyl-phenyl)-amide 
• 1265882-91-4 (1R,2R,4R)-4-[7-methoxy-8-methyl-2-(4-trifluoromethylthiazol-2-yl)-quinolin-4-yloxy]cyclohexane-1,2-dicarboxylic acid 2-benzyl ester 1-methyl ester 
• 1265882-92-5 (1R,2R,4R)-4-[7-methoxy-8-methyl-2-(4-trifluoromethylthiazol-2-yl)quinolin-4-yloxy]cyclohexane-1,2-dicarboxylic acid 2-benzyl ester 
• 1265882-93-6 (1R,2R,4R)-2-(hex-5-enylmethylcarbamoyl)-5-[7-methoxy-8-methyl-2-(4-trifluoromethylthiazol-2-yl)quinolin-4-yloxy]cyclohexane carboxylic acid benzyl ester 
• 1180495-35-5 4-trifluoromethyl-1,3-thiazole-2-carboxylic acid (6-acetyl-3-methoxy-2-methyl-phenyl)amide 
• 1093741-78-6 1-(2-Amino-4-hydroxy-3-methyl-phenyl)-ethanone 
• 1310551-67-7 1-[2-Amino-4-(2,2-dimethoxy-ethoxy)-3-methyl-phenyl]-ethanone 

Relevant articles and documents

Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants

The macrocyclic urea 2, a byproduct in the synthesis of benzoxaborole 1, was identified to be a novel and potent HCV protease inhibitor. We further explored this motif by synthesizing additional urea-based inhibitors and by characterizing them in replicase HCV protease-resistant mutants assay. Several compounds, exemplified by 12, were found to be more potent in HCV replicon assays than leading second generation inhibitors such as danoprevir and TMC-435350. Additionally, following oral administration, inhibitor 12 was found in rat liver in significantly higher concentrations than those reported for both danoprevir and TMC-435350, suggesting that inhibitor 12 has the combination of anti-HCV and pharmacokinetic properties that warrants further development of this series.

NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

The embodiments provide compounds of the general Formulae I, II, III, IV, V, VI, VII, and X, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

POLYMORPHIC FORMS OF A MACROCYCLIC INHIBITOR OF HCV

Provided are crystalline forms of the compound of formula (I), which is a macrocyclic inhibitor of HCV, processes for the preparation thereof, and pharmaceutical compositions comprising these crystalline forms.